Abstract
THE development of a vaccine to provide protective immunity to human immunodeficiency virus type 1 (HIV-1), the virus causing AIDS, would be the most practical method to control its spread. Subunit vaccines consisting of virus envelope glycoproteins, produced by recombinant DNA technology, are effective in preventing viral infections1. We have now used this approach in the development of a candidate AIDS vaccine. Chimpanzees were immunized with recombinant forms of the HIV-1 glycoproteins gp120 and gp160 produced in Chinese hamster ovary cells, and then challenged with HIV-1. The control and the two animals immunized with the gp160 variant became infected within 7 weeks of challenge. The two animals immunized with the gp120 variant have shown no signs of infection after more than 6 months. These studies demonstrate that recombinant gp120, formulated in an adjuvant approved for human use, can elicit protective immunity against a homologous strain of HIV-1.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 51 print issues and online access
$199.00 per year
only $3.90 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Scolnick, E. M. et al. J. Am. med. Assoc. 251, 2812–2815 (1984).
Lasky, L. A. et al. Science 233, 209–21 (1986).
Berman, P. W. et al. J. Virol. 63, 3489–3498 (1989).
Lasky, L. A. et al. Cell 50, 975–985 (1987).
Leonard, C. K. et al. J. biol. Chem. (in the press).
Berman, P. W., Gregory, T., Crase, D. & Lasky, L. A. Science 277, 1490–1492 (1985).
Berman, P. W. et al. Proc. natn. Acad. Sci. U.S.A. 85, 5200–5204 (1988).
Anderson, K. P. et al. J. infect. Diseases 160, 960–969 (1989).
Robertson, G. A., Kostek, B. M., Schleif, W. A., Lewis, J. A. & Emini, E. A. J. virol. Meth. 20, 195–202 (1988).
Arthur, L. O. J. Virol. 63, 5046–5053 (1989).
Prince, A. M. et al. Proc. natn. Acad. Sci. U.S.A. 85, 6944–6948 (1988).
Emini, E. A. et al. J. Virol. (in the press).
Kellog, D. E. & Kwok, S. in PCR Protocols (ed. Innis, M. A., Gelfand, D. H., Sninsky, J. J. & White, J.) 337–347 (Academic, New York, 1990).
Rusche, J. R. et al. Proc. natn. Acad. Sci. U.S.A. 85, 3198–3202 (1988).
Massey, R. J. & Schochetman, G. Science 213, 447–449 (1981).
Homsy, J., Meyer, Mia, Tateno, M., Clarkson, S. & Levy, J. A. Science 244, 1357–1359 (1989).
Robinson, E. W. Jr, Montefiori, D. C. & Mitchell, W. M. Lancet i, 790–794 (1988).
Robinson, E. W. Jr et al. Proc. natn. Acad. Sci. U.S.A. 87, 3185–3189 (1990).
Germain, R. N. Nature 322, 687–689 (1986).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Berman, P., Gregory, T., Riddle, L. et al. Protection of chimpanzees from infection by HIV-1 after vaccination with recombinant glycoprotein gp120 but not gp160. Nature 345, 622–625 (1990). https://doi.org/10.1038/345622a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/345622a0
This article is cited by
-
Monkeying around with HIV vaccines: using rhesus macaques to define 'gatekeepers' for clinical trials
Nature Reviews Immunology (2009)
-
Progress and obstacles in the development of an AIDS vaccine
Nature Reviews Immunology (2006)
-
Cytokine-adjuvanted HIV-DNA vaccination strategies
Springer Seminars in Immunopathology (2006)
-
Back to 'plan A'
Nature (2003)
-
HIV vaccines 1983–2003
Nature Medicine (2003)
Comments
By submitting a comment you agree to abide by our Terms and Community Guidelines. If you find something abusive or that does not comply with our terms or guidelines please flag it as inappropriate.
